{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:47:51Z","timestamp":1773420471945,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1983,1,1]],"date-time":"1983-01-01T00:00:00Z","timestamp":410227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1983]]},"DOI":"10.1007\/bf00542128","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T04:18:52Z","timestamp":1100837932000},"page":"557-561","source":"Crossref","is-referenced-by-count":26,"title":["Pinacidil, a new vasodilator: Pharmacokinetics and pharmacodynamics of a new retarded release tablet in essential hypertension"],"prefix":"10.1007","volume":"25","author":[{"given":"J. E.","family":"Carlsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kardel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. \ufffd.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tang\ufffd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Trap-Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF01975139","volume":"36","author":"E Arrigoni-Martelli","year":"1980","unstructured":"Arrigoni-Martelli E, Nielsen, CK, Olsen UB, Petersen HJ (1980) N?-cyano-N-4-pyridyl-N?-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): A new, potent vasodilator. Experientia 36: 445?447","journal-title":"Experientia"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1475-097X.1981.tb00905.x","volume":"1","author":"J Carlsen","year":"1981","unstructured":"Carlsen J, Kardel T, Hilden T, Tang\u00f8 M, Trap-Jensen J (1981) Immediate central and peripheral haemodynamic effects of P 1134, a new vasodilating agent in hypertensive man. Clin Physiol 1: 375?384","journal-title":"Clin Physiol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1128\/AAC.6.5.554","volume":"6","author":"H Engberg-Pedersen","year":"1974","unstructured":"Engberg-Pedersen H (1974) Empirical equation for pharmacokinetic analysis of drug serum levels after oral application. Antimicrob Agents Chemother 6: 554?562","journal-title":"Antimicrob Agents Chemother"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.0954-6820.1978.tb14899.x","volume":"203","author":"H Ibsen","year":"1978","unstructured":"Ibsen H, Rasmussen K, AErenlund Jensen H, Leth A (1978) Changes in plasma volume and extracellular fluid volume after addition of hydralazine to propranolol treatment in patients with hypertension. Acta Med Scand 203: 419?423","journal-title":"Acta Med Scand"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/00005344-198109000-00010","volume":"3","author":"T Kardel","year":"1981","unstructured":"Kardel T, Hilden T, Carlsen J, Trap-Jensen J (1981) P 1134, a new vasodilating agent. Acute effects on blood pressure and pharmacokinetics in hypertensive patients. J Cardiovasc Pharmacol 3: 1002?1007","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJM197608052950606","volume":"295","author":"J Koch-Weser","year":"1976","unstructured":"Koch-Weser J (1976) Hydralazine. N Engl J Med 295: 320?322","journal-title":"N Engl J Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1021\/jm00206a011","volume":"21","author":"HJ Petersen","year":"1978","unstructured":"Petersen HJ, Nielsen CH, Arrigoni-Martelli E (1978) Synthesis and hypotensive activity of N-alkyl-N?-cyano-N? pyridyl guanidines. J Med Chem 21: 773?781","journal-title":"J Med Chem"},{"key":"CR8","first-page":"575s","volume":"51","author":"RC Tarazi","year":"1976","unstructured":"Tarazi RC, Dustan Harriet, Bravo EL, Niarchos AP (1976) Vasodilating drugs: Contrasting haemodynamic effects. Clin Sci Mol Med 51: 575s-578s","journal-title":"Clin Sci Mol Med"},{"issue":"Suppl 1","key":"CR9","first-page":"1","volume":"20","author":"B \u00c5blad","year":"1963","unstructured":"\u00c5blad B (1963) A study of the mechanism of the haemodynamic effects of hydralazine in man. Acta Pharmacol Toxicol 20 [Suppl 1]: 1?53","journal-title":"Acta Pharmacol Toxicol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00542128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00542128\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00542128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T22:34:12Z","timestamp":1554417252000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00542128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1983]]}},"alternative-id":["BF00542128"],"URL":"https:\/\/doi.org\/10.1007\/bf00542128","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983]]}}}